(Q44217502)

30 November 2017

title

Studies on lactulose formulations for colon-specific drug delivery (English)

1 reference

30 November 2017

1 reference

1 reference

Masataka Katsuma

1

1 reference

30 November 2017

Shunsuke Watanabe

2

1 reference

30 November 2017

Hitoshi Kawai

3

1 reference

30 November 2017

Shigeo Takemura

4

1 reference

30 November 2017

Yoshinori Masuda

5

1 reference

30 November 2017

Muneo Fukui

6

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

International Journal of Pharmaceutics

30 November 2017

published in

1 reference

30 November 2017

volume

249

1 reference

30 November 2017

issue

1-2

1 reference

30 November 2017

page(s)

33-43

1 reference

An experiment to determine the active therapeutic moiety of sulphasalazine

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900429-5

7 January 2021

Comparison of canine and human gastrointestinal physiology

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900429-5

7 January 2021

Retention and transit of intestinal mucoadhesive films in rat small intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900429-5

7 January 2021

Preparation of enteric coated timed-release press-coated tablets and evaluation of their function by in vitro and in vivo tests for colon targeting

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900429-5

7 January 2021

Bioavailability of single and multiple doses of a new oral formulation of 5-ASA in patients with inflammatory bowel disease and healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900429-5

7 January 2021

In vitro adherence properties of Lactobacillus rhamnosus DR20 and Bifidobacterium lactis DR10 strains and their antagonistic activity against an enterotoxigenic Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900429-5

7 January 2021

Clinical course and long-term prognosis of Japanese patients with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900429-5

7 January 2021

Mechanism of action of 5-aminosalicylic acid and its derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900429-5

7 January 2021

Effect of particle size and food on gastric residence time of non-disintegrating solids in beagle dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900429-5

7 January 2021

Drug absorption from large intestine: physicochemical factors governing drug absorption

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900429-5

7 January 2021

Simple and sensitive high-performance liquid chromatographic assay for 5-aminosalicylic acid and acetyl-5-aminosalicylic acid in serum

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900429-5

7 January 2021

Effect of food intake on the delivery of fluorescein as a model drug in colon delivery capsule after oral administration to beagle dogs.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900429-5

7 January 2021

Determination of small intestinal transit time in beagle dogs using salicylazosulfapyridine

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900429-5

7 January 2021

The degradation of amino acids, proteins, and blood to short-chain fatty acids in colon is prevented by lactulose

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900429-5

7 January 2021

Evaluation of intestinal pressure-controlled colon delivery capsule containing caffeine as a model drug in human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900429-5

7 January 2021

Mesalamine in the treatment of mild to moderate active Crohn's ileitis: results of a randomized, multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900429-5

7 January 2021

Management of Crohn's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900429-5

7 January 2021

A new approach to the oral administration of insulin and other peptide drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900429-5

7 January 2021

Therapy of inflammatory bowel disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900429-5

7 January 2021

Olsalazine in active ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900429-5

7 January 2021

Azo polymeric hydrogels for colon targeted drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900429-5

7 January 2021

Application of a colon delivery capsule to 5-aminosalicylic acid and evaluation of the pharmacokinetic profile after oral administration to beagle dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900429-5

7 January 2021

Linear type azo-containing polyurethane as drug-coating material for colon-specific delivery: its properties, degradation behavior, and utilization for drug formulation

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900429-5

7 January 2021

10.1016/S0378-5173(02)00429-5

Identifiers

DOI

1 reference

30 November 2017

1 reference